• Explore /
  • Poster
  • / Low frequency <i>KRAS</i> G12/13 mutations in urine cell-free (cf) DNA from patients with <i>BRAF</i> V600E-mutant advanced cancers.

Low frequency KRAS G12/13 mutations in urine cell-free (cf) DNA from patients with BRAF V600E-mutant advanced cancers.

Abstract Poster

Authors

null

Filip Janku

Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX

Filip Janku , Cecile Rose T. Vibat , Gerald Steven Falchook , Helen J. Huang , David S. Hong , Sarina Anne Piha-Paul , Vivek Subbiah , Nishma M. Ramzanali , Saege Hancock , Aung Naing , Daniel D. Karp , Giovanni Nitti , Goran Cabrilo , Rajyalakshmi Luthra , Sapna Pradyuman Patel , Michael J. Overman , Scott Kopetz , Mark G. Erlander , Vlada Melnikova , Funda Meric-Bernstam

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Genomic and Epigenomic Biomarkers

Citation

J Clin Oncol 33, 2015 (suppl; abstr 11048)

DOI

10.1200/jco.2015.33.15_suppl.11048

Abstract #

11048

Poster Bd #

261

Abstract Disclosures

Similar Posters

First Author: Filip Janku

First Author: Jason C. Poole

Poster

2024 ASCO Annual Meeting

Characterization of diverse targetable <em>ERBB2</em> alterations in 512,993 patients with solid tumors.

Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.

First Author: Dazhi Liu

First Author: Christine Megerdichian Parseghian